Abstract

Synthetic biology and emerging genomic technologies offer vast potential but raise significant dual-use dilemmas, encompassing biosecurity, ethical implications, and the risk of misuse. This collection of papers highlights the need for a proactive approach, emphasizing responsible innovation, robust oversight, and international cooperation to navigate these challenges. The integration of Artificial Intelligence (AI) further complicates the landscape, requiring careful management. Ultimately, ensuring these powerful tools benefit humanity necessitates embedding safety and ethical considerations into their very core, fostering solutions over merely identifying threats, and establishing a global commitment to preventing harm.